Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies

医学 哮喘 内科学 重症监护医学
作者
Susanne Hansen,Marianne Baastrup Soendergaard,Anna von Bülow,Anne‐Sofie Bjerrum,Johannes Martin Schmid,Linda Makowska Rasmussen,Claus Rikard Johnsen,Truls Sylvan Ingebrigtsen,Kjell Erik Julius Håkansson,Sofie Lock Johansson,Maria Bisgaard,Karin Dahl Assing,Ole Hilberg,Charlotte Suppli Ulrik,Celeste Michala Porsbjerg
出处
期刊:Chest [Elsevier BV]
卷期号:165 (2): 253-266 被引量:152
标识
DOI:10.1016/j.chest.2023.10.046
摘要

Background The development of novel targeted biologic therapies for severe asthma has provided an opportunity to consider remission as a new treatment goal. Research Question How many patients with severe asthma treated with biologic therapy achieve clinical remission, and what predicts response to treatment? Study Design and Methods The Danish Severe Asthma Register is a nationwide cohort including all adult patients receiving biologic therapy for severe asthma in Denmark. This observational cohort study defined "clinical response" to treatment following 12 months as a ≥ 50% reduction in exacerbations and/or a ≥ 50% reduction in maintenance oral corticosteroid dose, if required. "Clinical remission" was defined by cessation of exacerbations and maintenance oral corticosteroids, as well as a normalization of lung function (FEV 1 > 80%) and an Asthma Control Questionnaire-6 score ≤ 1.5 following 12 months of treatment. Results Following 12 months of treatment, 104 (21%) of 501 biologic-naive patients had no response to treatment, and 397 (79%) had a clinical response. Among the latter, 97 (24%) fulfilled the study criteria of clinical remission, corresponding to 19% of the entire population. Remission was predicted by shorter duration of disease and lower BMI in the entire population of patients treated with biologic therapy. Interpretation Clinical response was achieved in most adult patients initiating biologic therapy, and clinical remission was observed in 19% of the patients following 12 months of treatment. Further studies are required to assess the long-term outcome of achieving clinical remission with biologic therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一生不怕强的水博完成签到,获得积分10
1秒前
Muhebbet完成签到,获得积分10
1秒前
哎呀完成签到,获得积分10
1秒前
wlywdb完成签到,获得积分10
1秒前
Sam十九完成签到,获得积分10
1秒前
小慈完成签到,获得积分10
1秒前
chen完成签到,获得积分10
1秒前
江十三完成签到,获得积分10
2秒前
TTORSH完成签到,获得积分10
2秒前
weila完成签到 ,获得积分10
2秒前
糟糕的修杰完成签到,获得积分10
2秒前
yinai完成签到,获得积分10
2秒前
真实的新瑶完成签到,获得积分10
3秒前
欧高完成签到 ,获得积分10
3秒前
青牛完成签到,获得积分10
3秒前
年轻的茗茗完成签到,获得积分10
3秒前
Carson完成签到,获得积分10
3秒前
12wsesd完成签到 ,获得积分10
4秒前
CodeCraft的应助被刘2305采纳,获得10
4秒前
jyg123456完成签到 ,获得积分10
5秒前
Spark完成签到,获得积分10
5秒前
木卡卡完成签到,获得积分10
6秒前
核桃发布了新的文献求助10
6秒前
含糊的寒蕾完成签到,获得积分10
6秒前
6秒前
冷静的凌波完成签到,获得积分10
7秒前
无奈孤兰完成签到,获得积分10
7秒前
LLLLL完成签到,获得积分10
7秒前
怡然剑成完成签到 ,获得积分0
8秒前
qdstisti完成签到,获得积分10
8秒前
牛大锤完成签到,获得积分10
8秒前
听话的幻竹完成签到,获得积分20
9秒前
9秒前
huazhangchina完成签到,获得积分10
9秒前
脆脆Shark完成签到,获得积分10
9秒前
YHX完成签到,获得积分10
9秒前
Blueyi完成签到,获得积分10
9秒前
iIl1oO0完成签到,获得积分10
10秒前
从容的犀牛完成签到,获得积分10
10秒前
sanqian911完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159212
求助须知:如何正确求助?哪些是违规求助? 9554678
关于积分的说明 21720538
捐赠科研通 7748887
什么是DOI,文献DOI怎么找? 3427184
关于科研通互助平台的介绍 2552092
邀请新用户注册赠送积分活动 2471464